Karolina Zawadzka
Karolina Zawadzka has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Artur Marcysiak
Mazowiecki Szpital Wojewódzki im. św. Jana Pawła II w Siedlcach, ul. Poniatowskiego 26, 08-110 Siedlce, Poland
8 shared publications - Magdalena Kiełbasiewicz
Nowodworskie Centrum Medyczne (Nowy Dwór Medical Center), ul. Miodowa 2, 05-100 Nowy Dwór Mazowiecki, Poland
8 shared publications - Małgorzata Sikorska
Nowodworskie Centrum Medyczne (Nowy Dwór Medical Center), ul. Miodowa 2, 05-100 Nowy Dwór Mazowiecki, Poland
8 shared publications - Nina Polek
Cardinal Stefan Wyszyński University in Warsaw, Warsaw, Poland
8 shared publications - Patrycja Mularczyk
Nowodworskie Centrum Medyczne (Nowy Dwór Medical Center), ul. Miodowa 2, 05-100 Nowy Dwór Mazowiecki, Poland
8 shared publications - Tomasz Mruzek
UCK WUM Centralny Szpital Kliniczny, ul. Banacha 1a, 02-097 Warszawa, Poland
8 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
NEW IMMUNOTHERAPY STRATEGIES FOR MELANOMA: CHECKPOINT INHIBITORS, COMBINATION THERAPIES AND mRNA VACCINES
Melanoma remains one of the most aggressive forms of skin cancer; however, the development of modern immunotherapeutic strategies has significantly improved the prognosis for a subset of patients. This review aims to discuss current and emerging treatment approaches based on modulation of the immune response, with particular emphasis on immune checkpoint inhibitors, targeted therapies, and mRNA vaccines. The mechanisms of action of antibodies targeting CTLA-4 and PD-1/PD-L1, their clinical efficacy, and the characteristic immune-related adverse events are presented. The review also discusses targeted therapies directed against BRAF and MEK mutations, as well as the rationale for combining these agents with immunotherapy to overcome treatment resistance. Furthermore, the emerging role of personalized mRNA vaccines designed according to the tumor neoantigen profile and the preliminary results of clinical trials are summarized. The importance of predictive biomarkers for patient selection and future directions in combination therapies are also highlighted. Overall, this review synthesizes the current state of knowledge and outlines promising opportunities for further improving treatment outcomes in patients with melanoma.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessNEW IMMUNOTHERAPY STRATEGIES FOR MELANOMA: CHECKPOINT INHIBITORS, COMBINATION THERAPIES AND mRNA VACCINES
Melanoma remains one of the most aggressive forms of skin cancer; however, the development of modern immunotherapeutic strategies has significantly improved the prognosis for a subset of patients. This review aims to discuss current and emerging treatment approaches based on modulation of the immune response, with particular emphasis on immune checkpoint inhibitors, targeted therapies, and mRNA vaccines. The mechanisms of action of antibodies targeting CTLA-4 and PD-1/PD-L1, their clinical efficacy, and the characteristic immune-related adverse events are presented. The review also discusses targeted therapies directed against BRAF and MEK mutations, as well as the rationale for combining these agents with immunotherapy to overcome treatment resistance. Furthermore, the emerging role of personalized mRNA vaccines designed according to the tumor neoantigen profile and the preliminary results of clinical trials are summarized. The importance of predictive biomarkers for patient selection and future directions in combination therapies are also highlighted. Overall, this review synthesizes the current state of knowledge and outlines promising opportunities for further improving treatment outcomes in patients with melanoma.
- Open Access
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
PREHABILITATION IN PATIENTS AWAITING LIVER TRANSPLANTATION – A REVIEW OF CURRENT EVIDENCE
End-stage liver disease (ESLD) is associated with significant metabolic disturbances, including chronic inflammation, hypercatabolism, and impaired protein synthesis, which lead to the development of sarcopenia and frailty. These conditions are common among patients qualified for liver transplantation and represent independent risk factors for waitlist mortality, postoperative complications, and prolonged hospitalization. Prehabilitation, defined as a multimodal intervention including physical training, nutritional optimization, and psychological support, aims to improve the patient’s physiological reserve prior to surgery. The aim of this study was a systematic evaluation of the available evidence regarding prehabilitation in liver transplant candidates, with particular emphasis on its impact on physical performance and clinical outcomes. Available data indicate that prehabilitation improves performance parameters such as VO₂peak and the 6-minute walk distance. However, its impact on hard clinical endpoints, including mortality and postoperative complications, remains inconclusive. Prehabilitation appears to be a safe and potentially beneficial intervention, particularly in frail patients; however, further high-quality studies are required.
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
Open AccessPREHABILITATION IN PATIENTS AWAITING LIVER TRANSPLANTATION – A REVIEW OF CURRENT EVIDENCE
End-stage liver disease (ESLD) is associated with significant metabolic disturbances, including chronic inflammation, hypercatabolism, and impaired protein synthesis, which lead to the development of sarcopenia and frailty. These conditions are common among patients qualified for liver transplantation and represent independent risk factors for waitlist mortality, postoperative complications, and prolonged hospitalization. Prehabilitation, defined as a multimodal intervention including physical training, nutritional optimization, and psychological support, aims to improve the patient’s physiological reserve prior to surgery. The aim of this study was a systematic evaluation of the available evidence regarding prehabilitation in liver transplant candidates, with particular emphasis on its impact on physical performance and clinical outcomes. Available data indicate that prehabilitation improves performance parameters such as VO₂peak and the 6-minute walk distance. However, its impact on hard clinical endpoints, including mortality and postoperative complications, remains inconclusive. Prehabilitation appears to be a safe and potentially beneficial intervention, particularly in frail patients; however, further high-quality studies are required.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
ARTIFICIAL INTELLIGENCE IN ORTHOPAEDIC SURGERY: CLINICAL APPLICATIONS, SOCIOECONOMIC IMPLICATIONS, AND FUTURE DIRECTIONS — A NARRATIVE REVIEW
Background: Artificial intelligence (AI) is transforming orthopaedic medicine, offering new possibilities for improving diagnostic accuracy, optimizing preoperative planning, and enhancing surgical precision. Despite growing evidence of algorithmic performance, clinical translation remains uneven, and a comprehensive synthesis of current evidence is needed to guide orthopaedic practice. This review also evaluates the socioeconomic implications of AI adoption, including clinical trust, accessibility, and the transformation of healthcare delivery models. Methods: This narrative review was conducted in March and April 2026 using PubMed/MEDLINE, Scopus, and Google Scholar. Publications in English from January 2018 to April 2026 were eligible. Methodological quality was assessed using the SANRA scale. A total of 48 sources were included. Results: Deep learning models achieve pooled sensitivity and specificity exceeding 90% in fracture detection on plain radiographs, with regulatory recognition by NICE confirming clinical readiness. AI demonstrates high accuracy in osteoarthritis grading and reduces morphometric measurement times by up to 87%. Deep learning MRI reconstruction reduces acquisition times by up to 90% while maintaining diagnostic quality. AI-driven 3D preoperative templating improves acetabular cup conformity from 72.2% to 90.9% over conventional 2D methods. Robotic-assisted total knee arthroplasty achieves significantly lower mechanical alignment outlier rates than conventional surgery, though short-term patient-reported outcomes remain comparable. Emerging applications include smart sensor-embedded implants, digital twin technology, and large language models supporting clinical documentation. Conclusions: AI demonstrates evidence-supported utility across orthopaedic diagnostics, surgical planning, and arthroplasty. Significant challenges persist regarding external validation, algorithmic transparency, regulatory harmonization, and equitable access. Future research should prioritize prospective multicenter trials, explainable AI frameworks, federated learning, and health economic analyses across diverse healthcare systems.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessARTIFICIAL INTELLIGENCE IN ORTHOPAEDIC SURGERY: CLINICAL APPLICATIONS, SOCIOECONOMIC IMPLICATIONS, AND FUTURE DIRECTIONS — A NARRATIVE REVIEW
Background: Artificial intelligence (AI) is transforming orthopaedic medicine, offering new possibilities for improving diagnostic accuracy, optimizing preoperative planning, and enhancing surgical precision. Despite growing evidence of algorithmic performance, clinical translation remains uneven, and a comprehensive synthesis of current evidence is needed to guide orthopaedic practice. This review also evaluates the socioeconomic implications of AI adoption, including clinical trust, accessibility, and the transformation of healthcare delivery models. Methods: This narrative review was conducted in March and April 2026 using PubMed/MEDLINE, Scopus, and Google Scholar. Publications in English from January 2018 to April 2026 were eligible. Methodological quality was assessed using the SANRA scale. A total of 48 sources were included. Results: Deep learning models achieve pooled sensitivity and specificity exceeding 90% in fracture detection on plain radiographs, with regulatory recognition by NICE confirming clinical readiness. AI demonstrates high accuracy in osteoarthritis grading and reduces morphometric measurement times by up to 87%. Deep learning MRI reconstruction reduces acquisition times by up to 90% while maintaining diagnostic quality. AI-driven 3D preoperative templating improves acetabular cup conformity from 72.2% to 90.9% over conventional 2D methods. Robotic-assisted total knee arthroplasty achieves significantly lower mechanical alignment outlier rates than conventional surgery, though short-term patient-reported outcomes remain comparable. Emerging applications include smart sensor-embedded implants, digital twin technology, and large language models supporting clinical documentation. Conclusions: AI demonstrates evidence-supported utility across orthopaedic diagnostics, surgical planning, and arthroplasty. Significant challenges persist regarding external validation, algorithmic transparency, regulatory harmonization, and equitable access. Future research should prioritize prospective multicenter trials, explainable AI frameworks, federated learning, and health economic analyses across diverse healthcare systems.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
GLP‑1 RECEPTOR AGONISTS IN THE MANAGEMENT OF OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: EFFECTS ON BODY WEIGHT, METABOLIC PROFILE, AND REPRODUCTIVE FUNCTION – A LITERATURE REVIEW
Objective: This dissertation synthesizes contemporary evidence on glucagon-like peptide-1 (GLP-1) receptor agonists in women with polycystic ovary syndrome (PCOS) and obesity, with emphasis on body weight, metabolic parameters, and reproductive outcomes. Methods: A narrative–systematic review (2012–2025) included randomized clinical trials, meta-analyses, and systematic and narrative reviews from PubMed, Embase, the Cochrane Library, Web of Science, and other databases. Studies of liraglutide, semaglutide, exenatide, and dulaglutide, as monotherapy or combined with metformin in women with PCOS, were analyzed with respect to anthropometric, metabolic, hormonal, and reproductive endpoints. Results: GLP-1 receptor agonists generally achieved greater reductions in body weight, BMI, and waist circumference than lifestyle modification or metformin alone, alongside improvements in insulin sensitivity, glycaemic control, and selected lipid measures. Decreases in androgen levels, attenuation of clinical hyperandrogenism, and improved menstrual regularity, ovulation rates, and pregnancy rates were reported, particularly in obese, markedly insulin-resistant women. Adverse events were mainly transient gastrointestinal symptoms. Conclusions: GLP-1 receptor agonists appear to be a promising adjunct to standard treatment of obese women with PCOS, enabling more effective weight loss, metabolic improvement, and potentially better cardiovascular prognosis, together with enhanced ovulatory and pregnancy outcomes. Nevertheless, the short duration of most studies, absence of safety data in pregnancy, and the requirement for contraception and wash out before conception highlight the need for long-term randomized trials evaluating efficacy, safety, and hard reproductive and cardiovascular endpoints.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessGLP‑1 RECEPTOR AGONISTS IN THE MANAGEMENT OF OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: EFFECTS ON BODY WEIGHT, METABOLIC PROFILE, AND REPRODUCTIVE FUNCTION – A LITERATURE REVIEW
Objective: This dissertation synthesizes contemporary evidence on glucagon-like peptide-1 (GLP-1) receptor agonists in women with polycystic ovary syndrome (PCOS) and obesity, with emphasis on body weight, metabolic parameters, and reproductive outcomes. Methods: A narrative–systematic review (2012–2025) included randomized clinical trials, meta-analyses, and systematic and narrative reviews from PubMed, Embase, the Cochrane Library, Web of Science, and other databases. Studies of liraglutide, semaglutide, exenatide, and dulaglutide, as monotherapy or combined with metformin in women with PCOS, were analyzed with respect to anthropometric, metabolic, hormonal, and reproductive endpoints. Results: GLP-1 receptor agonists generally achieved greater reductions in body weight, BMI, and waist circumference than lifestyle modification or metformin alone, alongside improvements in insulin sensitivity, glycaemic control, and selected lipid measures. Decreases in androgen levels, attenuation of clinical hyperandrogenism, and improved menstrual regularity, ovulation rates, and pregnancy rates were reported, particularly in obese, markedly insulin-resistant women. Adverse events were mainly transient gastrointestinal symptoms. Conclusions: GLP-1 receptor agonists appear to be a promising adjunct to standard treatment of obese women with PCOS, enabling more effective weight loss, metabolic improvement, and potentially better cardiovascular prognosis, together with enhanced ovulatory and pregnancy outcomes. Nevertheless, the short duration of most studies, absence of safety data in pregnancy, and the requirement for contraception and wash out before conception highlight the need for long-term randomized trials evaluating efficacy, safety, and hard reproductive and cardiovascular endpoints.
- Open Access
- 29 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
PRENATAL DIAGNOSIS OF INTERRUPTED AORTIC ARCH: A NARRATIVE REVIEW OF ECHOCARDIOGRAPHIC FINDINGS AND DIAGNOSTIC CHALLENGES
Interrupted aortic arch (IAA) is a rare but severe congenital heart defect characterized by the absence of luminal continuity between the ascending and descending aorta. Early prenatal diagnosis of IAA enables genetic evaluation, delivery planning and appropriate postnatal surgical management, thereby significantly improving neonatal outcomes. This narrative review aims to summarize current knowledge regarding the embryology, classification, associated anomalies, and prenatal echocardiographic diagnosis of fetal IAA, with particular emphasis on clinically relevant imaging features and diagnostic challenges. A literature-based review of previously published studies and clinical reports concerning fetal IAA was performed. Prenatal detection relies primarily on detailed echocardiography with four-chamber and three-vessel views. The second trimester appears to provide the most optimal conditions for diagnosis, as fetal size and position at that gestational age facilitate improved imaging. Characteristic findings of IAA include V-shaped, Y-shaped or W-shaped configurations of the aortic arch and lack of visible continuity between the ascending and descending aorta. Additional findings may include an abnormally shaped ductus arteriosus described as the “broken hockey stick” sign. Quantitative parameters suggestive of IAA include elevated pulmonary artery-to-aorta ratio (PA/Ao) and ventricular disproportion. IAA exhibits strong association with ventricular septal defect (VSD) and 22q11.2 deletion syndrome (especially type B IAA); therefore, detection of these abnormalities should prompt detailed assessment of the fetal aortic arch. Despite advances in fetal echocardiography, prenatal diagnosis remains challenging due to the rarity of IAA, variable presentation and overlapping echocardiographic features with other aortic arch anomalies, particularly coarctation of the aorta.
- 29 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessPRENATAL DIAGNOSIS OF INTERRUPTED AORTIC ARCH: A NARRATIVE REVIEW OF ECHOCARDIOGRAPHIC FINDINGS AND DIAGNOSTIC CHALLENGES
Interrupted aortic arch (IAA) is a rare but severe congenital heart defect characterized by the absence of luminal continuity between the ascending and descending aorta. Early prenatal diagnosis of IAA enables genetic evaluation, delivery planning and appropriate postnatal surgical management, thereby significantly improving neonatal outcomes. This narrative review aims to summarize current knowledge regarding the embryology, classification, associated anomalies, and prenatal echocardiographic diagnosis of fetal IAA, with particular emphasis on clinically relevant imaging features and diagnostic challenges. A literature-based review of previously published studies and clinical reports concerning fetal IAA was performed. Prenatal detection relies primarily on detailed echocardiography with four-chamber and three-vessel views. The second trimester appears to provide the most optimal conditions for diagnosis, as fetal size and position at that gestational age facilitate improved imaging. Characteristic findings of IAA include V-shaped, Y-shaped or W-shaped configurations of the aortic arch and lack of visible continuity between the ascending and descending aorta. Additional findings may include an abnormally shaped ductus arteriosus described as the “broken hockey stick” sign. Quantitative parameters suggestive of IAA include elevated pulmonary artery-to-aorta ratio (PA/Ao) and ventricular disproportion. IAA exhibits strong association with ventricular septal defect (VSD) and 22q11.2 deletion syndrome (especially type B IAA); therefore, detection of these abnormalities should prompt detailed assessment of the fetal aortic arch. Despite advances in fetal echocardiography, prenatal diagnosis remains challenging due to the rarity of IAA, variable presentation and overlapping echocardiographic features with other aortic arch anomalies, particularly coarctation of the aorta.
- Open Access
- 17 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
BIS/BAS PROFILES AND PSYCHOLOGICAL RESILIENCE: DIFFERENTIAL ASSOCIATIONS ACROSS THREE DIMENSIONS RELEVANT TO STRESS ADAPTATION AND MENTAL WELL-BEING
Psychological resilience is a component of mental health and well-being, yet the motivational mechanisms underlying its distinct dimensions remain insufficiently understood. This study examined whether the Behavioral Inhibition System (BIS) and the Behavioral Activation System (BAS) predict three forms of psychological resilience: engineering resilience, ecological resilience, and adaptive capacity. Data were collected in a two-wave online survey of 657 Polish adults from the general population. BIS/BAS were assessed using the BIS/BAS scales, and resilience was measured with the EEA Resilience Scale. Multiple regression and commonality analyses were conducted to examine the unique and shared contributions of motivational systems to resilience dimensions. Ecological resilience was positively predicted by BAS-Drive and BAS-Sensitivity to Reward, and negatively by BIS. Engineering resilience was primarily associated with lower BIS activation. Adaptive capacity was positively related to BAS-Pleasure Seeking and BAS-Sensitivity to Reward and negatively related to BIS. Commonality analysis further showed that BIS accounted for the largest share of variance in engineering resilience, whereas BAS-Drive and BAS-Sensitivity to Reward contributed most strongly to ecological resilience, and BAS-Pleasure Seeking to adaptive capacity. These findings suggest that psychological resilience is not a unitary construct, but is differentially associated with threat sensitivity and reward-related motivational tendencies, with implications for understanding stress adaptation and promoting mental health.
- 17 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessBIS/BAS PROFILES AND PSYCHOLOGICAL RESILIENCE: DIFFERENTIAL ASSOCIATIONS ACROSS THREE DIMENSIONS RELEVANT TO STRESS ADAPTATION AND MENTAL WELL-BEING
Psychological resilience is a component of mental health and well-being, yet the motivational mechanisms underlying its distinct dimensions remain insufficiently understood. This study examined whether the Behavioral Inhibition System (BIS) and the Behavioral Activation System (BAS) predict three forms of psychological resilience: engineering resilience, ecological resilience, and adaptive capacity. Data were collected in a two-wave online survey of 657 Polish adults from the general population. BIS/BAS were assessed using the BIS/BAS scales, and resilience was measured with the EEA Resilience Scale. Multiple regression and commonality analyses were conducted to examine the unique and shared contributions of motivational systems to resilience dimensions. Ecological resilience was positively predicted by BAS-Drive and BAS-Sensitivity to Reward, and negatively by BIS. Engineering resilience was primarily associated with lower BIS activation. Adaptive capacity was positively related to BAS-Pleasure Seeking and BAS-Sensitivity to Reward and negatively related to BIS. Commonality analysis further showed that BIS accounted for the largest share of variance in engineering resilience, whereas BAS-Drive and BAS-Sensitivity to Reward contributed most strongly to ecological resilience, and BAS-Pleasure Seeking to adaptive capacity. These findings suggest that psychological resilience is not a unitary construct, but is differentially associated with threat sensitivity and reward-related motivational tendencies, with implications for understanding stress adaptation and promoting mental health.
- Open Access
- 15 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
THE IMPACT OF RUNNING ON THE DEVELOPMENT OF KNEE OSTEOARTHRITIS: A LITERATURE REVIEW
Osteoarthritis (OA) is a highly prevalent chronic joint disease worldwide that causes pain, disability, and loss of function. The knee is the joint most commonly affected. The link between physical activity and OA remains a topic of debate in the medical community. Since running is one of the most popular forms of physical activity today, we decided to take a closer look at its connection to knee OA. This review synthesizes recent research on this topic. There is a disagreement in the literature: some researchers argue that running increases the risk of knee osteoarthritis, while others suggest it may have a protective effect. In this study, we conducted a comprehensive review of the literature concerning the effects of running on cartilage, as evaluated through imaging modalities and biochemical markers. We further examined its impact on patellofemoral joint pain, as well as the relationship between running duration and intensity. Additionally, we analyzed evidence on other risk factors for the condition and explored potential strategies to mitigate the adverse effects of running, as well as methods for the early detection of changes in the knee joint. We provide a holistic perspective on how running influences the development of knee osteoarthritis and highlight ongoing research directions to further improve outcomes.
- 15 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessTHE IMPACT OF RUNNING ON THE DEVELOPMENT OF KNEE OSTEOARTHRITIS: A LITERATURE REVIEW
Osteoarthritis (OA) is a highly prevalent chronic joint disease worldwide that causes pain, disability, and loss of function. The knee is the joint most commonly affected. The link between physical activity and OA remains a topic of debate in the medical community. Since running is one of the most popular forms of physical activity today, we decided to take a closer look at its connection to knee OA. This review synthesizes recent research on this topic. There is a disagreement in the literature: some researchers argue that running increases the risk of knee osteoarthritis, while others suggest it may have a protective effect. In this study, we conducted a comprehensive review of the literature concerning the effects of running on cartilage, as evaluated through imaging modalities and biochemical markers. We further examined its impact on patellofemoral joint pain, as well as the relationship between running duration and intensity. Additionally, we analyzed evidence on other risk factors for the condition and explored potential strategies to mitigate the adverse effects of running, as well as methods for the early detection of changes in the knee joint. We provide a holistic perspective on how running influences the development of knee osteoarthritis and highlight ongoing research directions to further improve outcomes.
- Open Access
- 15 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
GLP-1 RECEPTOR AGONISTS AND ALCOHOL USE DISORDER: A NARRATIVE REVIEW OF THERAPEUTIC POTENTIAL AND WELL-BEING OUTCOMES
Alcohol use disorder (AUD) remains a major global health challenge associated with substantial morbidity, mortality, and impaired well-being, while currently approved pharmacotherapies offer only modest and heterogeneous benefits. This narrative review examines the therapeutic potential of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in AUD, with particular attention to their neurobiological rationale, emerging clinical relevance, and broader implications for health and well-being. A structured narrative search of PubMed and Google Scholar, supplemented by reference screening, identified thirty-one relevant publications spanning preclinical studies, human observational analyses, randomized controlled trials, Mendelian randomization research, and review papers. Across preclinical models, GLP-1 receptor activation consistently reduced alcohol intake, reward-related responding, and relapse-like behaviour, supporting a mechanistic role for GLP-1 signalling in the modulation of mesolimbic reward pathways, gut–brain communication, and the interface between metabolic and motivational processes. Early human studies provide a promising but still inconclusive translational signal, with some trials reporting reductions in craving and selected drinking outcomes, while pooled randomized evidence remains limited and heterogeneous. Observational findings further suggest associations between GLP-1RA use and reduced alcohol-related events, although causal inference remains restricted. Overall, GLP-1RAs represent a biologically plausible and clinically promising, but still investigational, approach to AUD. Their potential to integrate metabolic and neurobehavioral dimensions of care may be especially relevant for improving long-term health outcomes, although larger and more rigorous trials are needed to define their efficacy, safety, and place in treatment.
- 15 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessGLP-1 RECEPTOR AGONISTS AND ALCOHOL USE DISORDER: A NARRATIVE REVIEW OF THERAPEUTIC POTENTIAL AND WELL-BEING OUTCOMES
Alcohol use disorder (AUD) remains a major global health challenge associated with substantial morbidity, mortality, and impaired well-being, while currently approved pharmacotherapies offer only modest and heterogeneous benefits. This narrative review examines the therapeutic potential of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in AUD, with particular attention to their neurobiological rationale, emerging clinical relevance, and broader implications for health and well-being. A structured narrative search of PubMed and Google Scholar, supplemented by reference screening, identified thirty-one relevant publications spanning preclinical studies, human observational analyses, randomized controlled trials, Mendelian randomization research, and review papers. Across preclinical models, GLP-1 receptor activation consistently reduced alcohol intake, reward-related responding, and relapse-like behaviour, supporting a mechanistic role for GLP-1 signalling in the modulation of mesolimbic reward pathways, gut–brain communication, and the interface between metabolic and motivational processes. Early human studies provide a promising but still inconclusive translational signal, with some trials reporting reductions in craving and selected drinking outcomes, while pooled randomized evidence remains limited and heterogeneous. Observational findings further suggest associations between GLP-1RA use and reduced alcohol-related events, although causal inference remains restricted. Overall, GLP-1RAs represent a biologically plausible and clinically promising, but still investigational, approach to AUD. Their potential to integrate metabolic and neurobehavioral dimensions of care may be especially relevant for improving long-term health outcomes, although larger and more rigorous trials are needed to define their efficacy, safety, and place in treatment.